is glp-1 good for diabetics Researchers find medications safe to continue before surgery in patients with diabetes and obesity Understanding semaglutide (GLP-1 RA): Are

Mattsson K, Nilsson-Condori E, Elmerstig E, et al

Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors, which may lead to slightly greater weight loss in some patients

Doctors may need to more closely monitor side effects and educate patients on maintenance dosing to curb high GLP-1 discontinuation rates

Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases

Reaching this state with a compound that has a short 5-Amino-1MQ half life requires careful, consistent, and often frequent dosing

Extended Duration and Body Weight Reduction Sustained Activation of Target Receptors The 68 day presence of Retatrutide in circulation enables persistent activation of GLP-1, GIP, and glucagon receptors between weekly injections